Securing medical device approvals from China’s National Medical Products Administration for new products or changes to existing products often takes longer than planned, leading to delays in product launches that can hinder business operations and add significant costs.
That is one finding in the EU Chamber of Commerce in China's 2024 business confidencesurvey, released in May
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?